Three stocks trading below $5 per share have attracted positive analyst coverage, with price targets suggesting substantial upside potential from current levels. Grab Holdings, the Southeast Asian ride-hailing and delivery platform, carries a median analyst price target implying 54% appreciation. Vaxart Inc., a clinical-stage biopharmaceutical company developing an oral vaccine platform, commands significantly higher expectations with analysts projecting 233% upside. ThredUp Inc., an online consignment marketplace, trades with a 190% median price target, indicating analyst confidence in the company's growth trajectory.
Despite recent market pullbacks affecting all three securities, analyst sentiment remains constructive regarding their long-term prospects. The stocks represent different market segments—including emerging market expansion, biotechnology innovation, and e-commerce infrastructure—each addressing distinct investor themes. Market observers suggest that capital rotation into small-capitalization and higher-risk equities could accelerate investor interest in these names throughout 2026, potentially supporting the analyst price targets.
Investors evaluating exposure to sub-$5 equities should conduct thorough due diligence, as this price tier typically carries elevated volatility and execution risk. Analyst price targets represent consensus views and do not guarantee future performance, particularly for early-stage and development-focused companies within this cohort.